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Background
Renal denervation (RDN) is an effective treatment for
resistant hypertension with expanding indications in the
hypertensive population [1]. The European Society of
Hypertension (ESH) guidelines [2], largely based on the
Symplicity trial inclusion criteria, state RDN should not be
performed if the patient has multiple renal arteries, renal
artery stenosis or renal arteries with a diameter of less
than 4 mm or length of less than 20 mm. Imaging prior to
consideration of RDN is recommended but has not been
included in all RDN trial protocols. The proportion of
hypertensive patients with anatomy suitable for RDN
using the current guidelines is not known.
Methods
A series of 112 consecutive contrast enhanced magnetic
resonance angiograms performed at our institution for
investigation of hypertension over a period of one year
(September 2012-2013) were retrospectively analysed for
anatomic suitability for RDN. Images were acquired
using a dedicated 1.5T scanner with an eight-channel
phased-array receiver coil (Siemens Magnetom Avanto).
Multiplanar reconstruction and raw images were assessed
for the presence of accessory renal arteries and renal
artery stenosis. Renal artery dimensions were measured
by two operators blinded to clinical results.
Results
The population was 60% male with a mean age of 48 ±
17 years. 38% (n = 42) of patients had multiple renal
arteries, including 5% with bilateral dual renal artery
supply. 5% (6 patients) had significant renal artery
stenosis. Agreement between operators for vessel
dimensions was good (weighted kappa 0.6). The mean
main renal artery calibre was 6.3 ± 3.5 mm. 25 patients
(22%) had at least one main renal artery with a diameter
less than 4 mm. While accessory renal arteries were
smaller than main renal arteries, with a mean diameter of
3.3 ± 1.1 mm, 28% had a diameter of 4 mm or greater.
One patient (0.8%) had a renal artery length less than
20 mm. Overall, 30% of patients did not meet the current
anatomic criteria for RDN.
Conclusions
Under the current ESH guidelines, 30% of the hyperten-
sive patients studied had anatomy unsuitable for RDN
under the current guidelines, most commonly due to the
presence of accessory renal arteries. Our data support the
use of non-invasive renal angiography prior to considera-
tion of RDN and may prompt further studies of safety
and efficacy in populations with anatomy outside of cur-
rent guidelines. While accessory arteries were usually
small, a significant proportion (28%) were of sufficient
calibre for RDN and in these cases, an approach targeting
accessory as well as main renal arteries may be suitable.
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